THE STATE OF LONG-TERM AUTOIMMUNE AND INFLAMMATORY REACTIONS AFTER COVID-19
M.I. Lisyany, L.M. Belskaya, A.I. Klyuchnikova, E.P. Krasilenko
SI “Institute of Neurosurgery of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz68.05.003
Abstract
The purpose of this work was a comparative study of the state
of inflammatory reactions and the level of autoantibodies to
neuroantigens in COVID-19 previously infected and vaccinated persons. People who have experienced a COVID-19 infection had an increased level of CRP, medium-mass molecules, in their blood serum. This indicates the persistence of a
long-term inflammatory reaction after the infection. The level
of autoantibodies to neuroproteins in blood sera was increased
both in the groups of COVID-19 previously infected and
vaccinated patients in comparison with persons who have not
undergo the disease. This indicates the activation of humoral
neuroautoimmune reactions, which can lead to the activation
and development of progressive neurological complications
in a remote period after infection. The level of anti-covid antibodies was 2-3 times higher in vaccinated than in COVID-19
previously infected persons, in the last group both high and low
titers of antibodies were registered. This indirectly indicates
possible re-infection and the need to vaccinate persons who
already had experienced the infection. Subjects who have not
suffered from COVID-19 show lower signs of intoxication,
inflammation, and levels of neuroautoantibodies occurred if
compare to other groups. In addition, the titer of specific anticovid antibodies was significantly low; this indicates a lack of
humoral immunity to the COVID-19 virus. The reasons and
mechanisms of such a “resistance” to infection are unclear
and represent a certain scientific and practical interest for
further study.
Keywords:
COVID-19-infection; inflammation; neuroautoimmune reactions
References
- Lukiw W, Pogue A, Hill J. SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol. 2020;1-8(10):1007.
CrossRef
PubMed PubMedCentral
- Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020;92(7):699-702.
CrossRef
PubMed PubMedCentral
- Kornatskyi V, Ryzhkova O, Gavrilenko T, Dorokhina A, et al. IgG, IgM and neutralizing antibodies to SARS-COV-2 in medical workers during the year (2020-2021) before the start of mass vaccination. Fiziol Zh. 2022;68(3):44-50.
CrossRef
- Matias-Guiu J, Gomez-Pinedo U, Montero-Escribano P, Gomez-Iglesias P, Porta-Etessam J, Matias-Guiu J. Should we expect neurological symptoms in the SARSCoV-2 epidemic? Neurologia. 2020;35(3):170.
CrossRef
PubMedCentral
- Yang N, Shen H-M. Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19. Int J Biol Sci. 2020;16(10):1724-31.
CrossRef
PubMed PubMedCentral
- Sanclemente-Alaman I, Moreno-Jiménez L, Benito-Martín M, Canales-Aguirre A, Matías-Guiu J, Matías-Guiu J, et al. Experimental models for the study of central nervous system infection by SARS-CoV-2. Front Immunol. 2020;(11):2163.
CrossRef
PubMed PubMedCentral
- Bullen C, Hogberg H, Bahadirli-Talbott A, Bishai W, Hartung T, Keuthan C, et al. Infectability of human brain sphere neurons suggests neurotropism of SARS-CoV-2. 2020;37(4):665-71.
CrossRef
PubMed
- Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183(1):16-27.
CrossRef
PubMed PubMedCentral
- Kim W, Corey S, Alvarez X, Williams K. Monocyte/ macrophage traffic in HIV and SIV encephalitis. J Leuk Biol. 2003;74(5):650-6.
CrossRef
PubMed
- Lisyany N. COVID-19 infection and autoimmune reactions. Fiziol Zh. 2022;68(1):87-92. [Ukrainian].
CrossRef
- Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90.
CrossRef
PubMed PubMedCentral
- Baig A, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995.
CrossRef
PubMed PubMedCentral
- Yavarpour-Bali H, Ghasemi-Kasman M. Update on neurological manifestations of COVID-19. Life Sci. 2020;257:118063.
CrossRef
PubMed PubMedCentral
- 14.Zubair A, McAlpine L, Gardin T, Farhadian S, Kuruvilla D, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of Coronavirus disease 2019: A Review. JAMA Neurol. 2020;77(8):1018-27.
CrossRef
PubMed PubMedCentral
- Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183(1):16-27.
CrossRef
PubMed PubMedCentral
- Dey J, Alam MT, Chandra S, Gupta J, Ray U, Srivastava AK, et al. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of respiratory center of the brain. J Med Virol. 2020;1-8.
CrossRef
PubMed
- Miner J, Diamond M. Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier. Curr Opin Immunol. 2016;(38):18-23.
CrossRef
PubMed PubMedCentral
- Desforges M, Miletti TC, Gagnon M, Talbot PJ. Activation of human monocytes after infection by human coronavirus 229E. Virus Res. 2007;130(1):228-40.
CrossRef
PubMed PubMedCentral
- Barrantes F. Central nervous system targets and routes for SARS-CoV-2: current views and new hypotheses. ACS Chem Neurosci. 2020;11(18):2793-803.
CrossRef
PubMed PubMedCentral
- Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41(10):2657-69.
CrossRef
PubMed PubMedCentral
- Lisyany N. Immunology and immunotherapy of multiple sclerosis. Kyiv. 2003.
- Frimel G. Immunological methods. Medicine. 1987.
- Gavrilov V, Bidula M, Furmanchuk D, Konev S, Aleinikova V. Evaluation of intoxication of the body by the imbalance between the accumulation and binding of toxins in the blood plasma. Clin Lab Diagn. 1999;(2):13-5.
|